Evidence map›Paper›PMID 41306115›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Risk prediction of mild cognitive impairment using electronic health record data.

Gang Li, Bryan Cobb, Todd M Nelson, Viswanath Devanarayan, Stephane Borentain, Michelle M Mielke, James E Galvin, Miia Kivipelto, Rifky Tkatch, Susan De Santi and 7 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Gang LiGlobal Medical Affairs Eisai Inc. Nutley New Jersey USA.
Bryan CobbGlobal Medical Affairs Eisai Inc. Nutley New Jersey USA.
Todd M NelsonGlobal Medical Affairs Eisai Inc. Nutley New Jersey USA.
Viswanath DevanarayanGlobal Medical Affairs Eisai Inc. Nutley New Jersey USA.
Stephane BorentainGlobal Medical Affairs Eisai Inc. Nutley New Jersey USA.
Michelle M MielkeDepartment of Epidemiology and Prevention Wake Forest University School of Medicine Winston-Salem North Carolina USA.
James E GalvinComprehensive Center for Brain Health, Department of Neurology University of Miami Miller School of Medicine Miami Florida USA.
Miia KivipeltoDivision of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society Karolinska Institute Stockholm Sweden.
Rifky TkatchGlobal Medical Affairs Eisai Inc. Nutley New Jersey USA.
Susan De SantiGlobal Medical Affairs Eisai Inc. Nutley New Jersey USA.
Feride FrechGlobal Medical Affairs Eisai Inc. Nutley New Jersey USA.
Jo VandercappellenGlobal Medical Affairs Eisai Inc. Nutley New Jersey USA.
Yosuke NakamuraGlobal Medical Affairs Eisai Inc. Nutley New Jersey USA.
Richard CrislipDepartment of Behavioral Health OptumCare Phoenix Arizona USA.
Jeffrey MeyerhoffDepartment of Whole Health Behavioral Health Solutions Optum Behavioral Health Eden Prairie Minnesota USA.
Soeren MattkeCenter for Economic and Social Research University of Southern California Los Angeles California USA.
Harald HampelGlobal Medical Affairs Eisai Inc. Nutley New Jersey USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMild cognitive impairment (MCI) is underdiagnosed by primary care providers (PCPs), with detection rates as low as 6%-15%. Predictive models support the identification of individuals at risk, enabling timely intervention.

methodsThis retrospective study was conducted on 271,054 cognitively unimpaired and 14,501 confirmed MCI cohorts from electronic health records. A machine learning model was developed with a data-driven variable selection approach based on demographics and comorbidities.

resultsFrom 101 variables, 26 were chosen for the final model, achieving an overall area under the curve (AUC) of 86%. Age-stratified AUCs were 79.1% (40-49), 77.0% (50-64), 76.9% (65-79), and 74.4% (≥80), showing the highest predictive performance in younger age groups. DISCUSSION: Demographic factors and comorbidities can serve as effective predictors for the risk of MCI. The model demonstrates strong predictive performance and assists as a triage tool for PCPs, facilitating the identification of individuals with MCI for early treatment. Highlights: Predictive algorithms using electronic health records (EHRs) are useful for identifying individuals at risk for mild cognitive impairment (MCI) to triage for further clinical evaluation.A machine learning model was developed using EHR data to predict those at risk for MCI.The model identified 26 variables that were able to distinguish the MCI from non-MCI cohorts.The model accurately detected MCI across the cohort (area under the curve [AUC] = 86%) and trended best for younger age groups (AUC was 77%, 77%, and 74% in 50-64, 65-79, and ≥80 age groups, respectively).Implementation of a triage tool could be used to detect MCI across aging patient populations sooner, leading to a timelier diagnosis, intervention, and treatment management.

Indexed as

Alzheimer's diseasecognitive declinecognitive impairmentdeep learningdementiaelectronic health record datamachine learningmild cognitive impairmentpredictive algorithmpredictive modelingpredictive toolrisk prediction

Identifiers

PMID41306115
PMCPMC12644922

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.